Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating avelumab with fluorouracil and mitomycin or with cisplatin and radiation therapy for muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update for HX008 in BCG-unresponsive non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors [Phase 2]
Phase 2 trial assessing efficacy and safety of LDP in patients with bladder cancer, renal carcinoma, and advanced penile carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Treatment of Recurrent Bladder Cancer With Dendritic Cells [Phase 2]
Phase 2 clinical trial evaluating dendritic cell therapy for recurrent bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors [Phase 2]
Phase 2 clinical trial evaluating tamoxifen for low/intermediate risk bladder tumors has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma [Phase 2]
Phase 2 study update for F520 in locally advanced or metastatic urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial update on toripalimab with nab-paclitaxel with or without cisplatin as first-line treatment for urothelial carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating genomics-guided therapy selection in advanced urothelial carcinoma/bladder cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer [Phase 1, Phase 2]
Clinical trial update on radiation therapy with combination chemotherapy for stage II/III bladder cancer, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial of rucaparib in locally advanced or metastatic urothelial carcinoma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function [Phase 2]
Phase 2 trial evaluating a combination of gemcitabine, paclitaxel, and doxorubicin in metastatic or unresectable bladder cancer with decreas…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Perioperative Analgesic Efficiency of Quadratus Lumborum Block vs Epidural in Radical Cystectomy [Phase 2]
Phase 2 trial comparing quadratus lumborum block to epidural for perioperative analgesia in radical cystectomy has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer [Phase 2]
Phase 2 clinical trial evaluating erlotinib hydrochloride in patients with muscle-invasive or recurrent urothelial cancer has completed, wit…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Tranexamic Acid Infusion in Low Dose Versus in High Dose for Reducing Blood Loss in Radical Cystectomy Operations [Phase 4]
Phase 4 trial evaluating low-dose versus high-dose tranexamic acid infusion to reduce blood loss during radical cystectomy.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial of avelumab in non-metastatic muscle-invasive bladder cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer [Phase 2]
Phase 2 trial evaluating erlotinib combined with Green Tea Extract (Polyphenon E) for preventing cancer recurrence after bladder cancer surg…
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Propranolol Adjuvant Treatment of Bladder Cancer [Phase 2]
Phase 2 trial update on propranolol as adjuvant treatment for bladder cancer is in early-stage development with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Evaluation of Naloxegol in the Prevention of POI After Cystectomy [Phase 2]
Phase 2 clinical trial evaluating naloxegol for preventing postoperative ileus after cystectomy.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery [Phase 2]
Phase 2 clinical trial of erlotinib hydrochloride in bladder cancer patients undergoing surgery was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders [Phase 4]
Phase 4 clinical trial evaluating mebeverine for daytime and nocturnal incontinence after orthotopic ileal neobladders; completed.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Study of Tumour Focused Radiotherapy for Bladder Cancer [Phase 2]
Phase 2 clinical trial update on tumour-focused radiotherapy for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ [Phase 2]
Phase 2 clinical trial update for Vicinium in non-invasive urothelial carcinoma in situ of the bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. [Phase 3]
Phase 3 clinical trial investigating mitomycin C intravesical chemotherapy with Synergo radiofrequency-induced hyperthermia for Bacillus Cal…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) [Phase 2]
Phase 2 trial evaluating durvalumab plus olaparib given before surgery in resectable bladder cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer [Phase 2]
A Phase 2 clinical trial update exploring chemotherapy as an alternative to surgery for low-risk bladder cancer.